The haemodynamic effects of labetalol, ketanserin and a placebo at the end of a NLA. A double blind study.
D000293:Adolescent; D000328:Adult; D000368:Aged; D004311:Double-Blind Method; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007650:Ketanserin; D007741:Labetalol / Q000494:pharmacology*; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology*; D010919:Placebos; D011897:Random Allocation; D012702:Serotonin Antagonists / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*
D004983:Ethanolamines; D010880:Piperidines; D010919:Placebos; D012702:Serotonin Antagonists; D013565:Sympatholytics; D007650:Ketanserin; D007741:Labetalol